期刊文献+

肺血栓栓塞症患者血小板功能和血清抗心磷脂抗体的变化及意义 被引量:8

Changes of the platelet function and serum anticardiolipin antibody in patients with pulmonary thromboembolism
原文传递
导出
摘要 目的 探讨肺血栓栓塞症 (PTE)患者溶栓和抗凝治疗前后血小板功能和血清抗心磷脂抗体 (ACA)的变化及临床意义。方法 选择经螺旋CT肺动脉造影确诊的PTE患者 4 8例为病例组 ,年龄、身高、体重相匹配的健康者 2 0名为对照组。用流式细胞仪检测血小板膜上P 选择素、糖蛋白Ⅱb/Ⅲa(GPⅡb/Ⅲa)的变化 ;酶联免疫吸附试验 (ELISA)法检测血浆血栓素B2 (TXB2 )、6 酮 前列腺素F1α(6 Keto PGF1α)、血管性假血友病因子 (vWF)、D 二聚体和血清ACA ,并比较溶栓和抗凝治疗前及治疗 1周时各项指标的变化。结果 病例组P 选择素、GPⅡb/Ⅲa、vWF、TXB2 、D 二聚体、TXB2 / 6 Keto PGF1α(T/K)分别为 (12 4 2± 7 0 3) %、(19 6± 12 5 ) %、(3 8± 1 9)mg/L、(194 5± 2 3 1) %、(341 1±4 2 6 )ng/L、(5 7 3± 19 2 ) ,显著高于对照组的 (2 2 0± 1 5 0 ) %、(1 8± 0 9) %、(0 3± 0 1)mg/L、(99 8± 2 2 8) %、(5 3 7± 16 8)ng/L、(3 4± 1 5 ) ,两组相比差异有显著性 (P均 <0 0 1) ;而 6 Keto PGF1α为(6 7± 2 8)ng/L ,显著低于对照组的 (16 8± 2 6 )ng/L ,差异有显著性 (P <0 0 1)。ACA IgG、IgA显著高于对照组 (P <0 0 1)。PTE患者经治疗 1周后 6 Keto PGF1α较治疗前明显升高 (P Objective To explore the changes of the platelet function and serum anticardiolipin antibody(ACA) in patients with pulmonary thromboembolism(PTE). Methods Forty-eight patients with PTE diagnosed by spiral computed tomographic pulmonary angiography(CTPA) were included as the trial group, while 20 person in which PTE was excluded served as the control group. P-selectin,and GPⅡb/Ⅲa expressed on platelets were measured by flow cytometry,and plasma TXB 2,6-Keto-PGF1α,vWF,D-dimer and serum ACA were measured by ELISA and the changes of these parameters were compared 1 week later. Results In the trial group, the levels of P-selectin, GPⅡb/Ⅲa,TXB 2, vWF, D-dimer and T/K were significantly higher than those in the control group (P<0.01). But the plasma level of 6-Keto-PGF1α in the patients with PTE was significantly lower than that in the control group (P<0.01). The levels of ACA-IgG and ACA-IgA were significantly higher than those in the control group (P<0.01). After therapy the level of 6-Keto-PGF1α was significantly higher than that before therapy(P<0.01),and other parameters were significantly lower than those before therapy(P<0.01). P-selectin,GPⅡb/Ⅲa and vWF were positively correlated with D-dimer (P<0.01). Conclusion Endothelium damage, platelet activation and hypercoagulation combined with fibrinolytic activation occur in patients with PTE.
出处 《中华结核和呼吸杂志》 CAS CSCD 北大核心 2004年第11期731-734,共4页 Chinese Journal of Tuberculosis and Respiratory Diseases
关键词 患者 对照组 6-KETO-PGF1Α 血清 GPⅡb/Ⅲa 血小板功能 PTE 变化 结论 显著性 Pulmonary embolism Platelet activation Platelet membrane glycoproteins Endothelium,vascular
  • 相关文献

参考文献11

  • 1Silverstein MD, Heit JA, Mohr DN, et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med, 1998,158:585-593.
  • 2Nielsen HK. Pathophysiology of venous thromboembolism. Semin Thromb Hemost, 1991,17 Suppl 3:250-253.
  • 3Garcia-Szabo R, Johnson A, Malik AB. Thromboxane increases pulmonary vascular resistance and transvascular fluid and protein exchange after pulmonary microembolism. Prostaglandins, 1988,35:707-721.
  • 4Madan M, Berkowitz SD, Tcheng JE. Glycoprotein Ⅱb/Ⅲa integrin blockade. Circulation,1998,98:2629-2635.
  • 5Lip GY, Lowe GD. Fibrin D-dimer: a useful clinical marker of thrombogenesis? Clin Sci, 1995,89:205-214.
  • 6Bick RL, Baker WF. Antiphospholipid and thrombosis syndromes. Semin Thromb Hemost, 1994,20:3-15.
  • 7Brighton TA, Chesterman CN. Antiphospholipid antibodies and thrombosis. Baillieres Clin Haematol, 1994,20:71-78.
  • 8谢敏,王曾礼.慢性阻塞性肺病的血栓前状态[J].中华内科杂志,1998,37(9):616-617. 被引量:95
  • 9刘泽英,刘双,肖瑶,赵秀清,左大鹏.52例肺栓塞治疗前后纤维蛋白原和D二聚体的变化[J].心肺血管病杂志,2000,19(3):168-169. 被引量:21
  • 10周永列,刘建栋.D-二聚体的测定及其临床意义[J].国外医学(临床生物化学与检验学分册),1996,17(1):4-6. 被引量:121

二级参考文献15

  • 1刘蕴忠,刘秀杰,张卫和,吴清文,周宝贵.放射性核素肺断层显像的初步应用[J].中华核医学杂志,1995,15(3):192-192. 被引量:2
  • 22,MorpurgoM,SchruinC.Clinico-pathologicalcorrelationsinpulmonaryembolism:aposteriorevaluation.ProgRespirRes,1980,13:8.
  • 33,AhucedK,SaeedE,Nephroticsyndromeandpulmonaryarterythrombosis.AmJNephrol,1995,15:274~276.
  • 44,DoisclairMD,laneDA,WildeJT,etal.AComparativeevaluationand/orfibrinolysis:thrombin-antithrombincomplex,D-dimerandfibrinogeryfibrinfragmentEantigen.BrJHaematol,1990,74:471.
  • 55,LawlerCM,BovillEG,StumpDCetal.FibrinfragmentD-dimerandfibrinogenBpeptidesinplasmaasmarkersofclotlysisdurinythrombolytictherapyinacutemyccardialinfarction.Blood,1990,76:1341. 1999-10-12收稿,1999-12-22修回
  • 6HorkkoS,MillerE,BranchDW ,etal. Proceedings of the National Academy of Sciences of the United States of America . 1997
  • 7Vaarala O,Manttari M,Manninen V,et al. Circulation . 1995
  • 8Baca V,Garcia RR,Ramirez LM,et al. The Journal of Rheumatology . 1996
  • 9Silver RK,McGregor SN,Pasternak JN,et al. Obstetrics and Gynecology . 1992
  • 10Takanashi J,Sugita K,Miyazato S,et al. Pediatric Neurology . 1995

共引文献241

同被引文献70

引证文献8

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部